IQVIA Holdings Future Growth
Future criteria checks 4/6
IQVIA Holdings is forecast to grow earnings and revenue by 13.8% and 5.3% per annum respectively. EPS is expected to grow by 13.4% per annum. Return on equity is forecast to be 31.4% in 3 years.
Key information
13.8%
Earnings growth rate
13.4%
EPS growth rate
Life Sciences earnings growth | 26.2% |
Revenue growth rate | 5.3% |
Future return on equity | 31.4% |
Analyst coverage | Good |
Last updated | 20 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 17,179 | 1,793 | 2,471 | 3,082 | 17 |
12/31/2025 | 16,243 | 1,536 | 2,148 | 2,735 | 22 |
12/31/2024 | 15,406 | 1,338 | 1,882 | 2,478 | 22 |
9/30/2024 | 15,315 | 1,405 | 1,961 | 2,578 | N/A |
6/30/2024 | 15,155 | 1,423 | 1,827 | 2,440 | N/A |
3/31/2024 | 15,069 | 1,357 | 1,624 | 2,254 | N/A |
12/31/2023 | 14,984 | 1,358 | 1,500 | 2,149 | N/A |
9/30/2023 | 14,855 | 1,116 | 1,321 | 1,962 | N/A |
6/30/2023 | 14,681 | 1,096 | 1,582 | 2,242 | N/A |
3/31/2023 | 14,494 | 1,055 | 1,508 | 2,169 | N/A |
12/31/2022 | 14,410 | 1,091 | 1,586 | 2,260 | N/A |
9/30/2022 | 14,307 | 1,182 | 1,705 | 2,392 | N/A |
6/30/2022 | 14,136 | 1,160 | 1,689 | 2,373 | N/A |
3/31/2022 | 14,033 | 1,079 | 1,915 | 2,583 | N/A |
12/31/2021 | 13,874 | 966 | 2,302 | 2,942 | N/A |
9/30/2021 | 13,536 | 767 | 2,368 | 3,000 | N/A |
6/30/2021 | 12,931 | 607 | 2,103 | 2,730 | N/A |
3/31/2021 | 12,014 | 409 | 2,039 | 2,663 | N/A |
12/31/2020 | 11,359 | 279 | 1,343 | 1,959 | N/A |
9/30/2020 | 10,956 | 176 | 1,215 | 1,792 | N/A |
6/30/2020 | 10,939 | 132 | 979 | 1,548 | N/A |
3/31/2020 | 11,158 | 215 | 885 | 1,467 | N/A |
12/31/2019 | 11,088 | 191 | 835 | 1,417 | N/A |
9/30/2019 | 10,881 | 244 | 668 | 1,251 | N/A |
6/30/2019 | 10,706 | 247 | 708 | 1,265 | N/A |
3/31/2019 | 10,533 | 248 | 673 | 1,185 | N/A |
12/31/2018 | 10,412 | 259 | 795 | 1,254 | N/A |
9/30/2018 | 10,245 | 1,217 | 647 | 1,070 | N/A |
6/30/2018 | 10,117 | 1,245 | N/A | 1,162 | N/A |
3/31/2018 | 9,905 | 1,246 | N/A | 1,096 | N/A |
12/31/2017 | 9,702 | 1,277 | N/A | 970 | N/A |
9/30/2017 | 9,133 | 72 | N/A | 1,184 | N/A |
6/30/2017 | 7,804 | 84 | N/A | 1,008 | N/A |
3/31/2017 | 6,616 | 108 | N/A | 804 | N/A |
12/31/2016 | 6,815 | 72 | N/A | 860 | N/A |
9/30/2016 | 4,540 | 397 | N/A | 620 | N/A |
6/30/2016 | 4,497 | 409 | N/A | 643 | N/A |
3/31/2016 | 4,404 | 408 | N/A | 652 | N/A |
12/31/2015 | 4,326 | 387 | N/A | 476 | N/A |
9/30/2015 | 4,262 | 371 | N/A | 525 | N/A |
6/30/2015 | 4,229 | 352 | N/A | 379 | N/A |
3/31/2015 | 4,191 | 353 | N/A | 396 | N/A |
12/31/2014 | 4,165 | 357 | N/A | 433 | N/A |
9/30/2014 | 4,106 | 341 | N/A | 391 | N/A |
6/30/2014 | 3,977 | 315 | N/A | 431 | N/A |
3/31/2014 | 3,886 | 268 | N/A | 386 | N/A |
12/31/2013 | 3,808 | 227 | N/A | 393 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IQVH's forecast earnings growth (13.8% per year) is above the savings rate (1.4%).
Earnings vs Market: IQVH's earnings (13.8% per year) are forecast to grow faster than the Austrian market (9% per year).
High Growth Earnings: IQVH's earnings are forecast to grow, but not significantly.
Revenue vs Market: IQVH's revenue (5.3% per year) is forecast to grow faster than the Austrian market (0.7% per year).
High Growth Revenue: IQVH's revenue (5.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: IQVH's Return on Equity is forecast to be high in 3 years time (31.4%)